成雅, 王海芳, 袁瑞华, 董静, 刘勤社. ADAM17与心血管疾病的相关性研究进展[J]. 心脏杂志, 2021, 33(2): 199-204. DOI: 10.12125/j.chj.202009015
    引用本文: 成雅, 王海芳, 袁瑞华, 董静, 刘勤社. ADAM17与心血管疾病的相关性研究进展[J]. 心脏杂志, 2021, 33(2): 199-204. DOI: 10.12125/j.chj.202009015
    Ya CHENG, Hai-fang WANG, Rui-hua YUAN, Jing DONG, Qin-she LIU. Research advance in correlation between a disintegrin and metalloproteinase 17 (ADAM17) and cardiovascular diseases[J]. Chinese Heart Journal, 2021, 33(2): 199-204. DOI: 10.12125/j.chj.202009015
    Citation: Ya CHENG, Hai-fang WANG, Rui-hua YUAN, Jing DONG, Qin-she LIU. Research advance in correlation between a disintegrin and metalloproteinase 17 (ADAM17) and cardiovascular diseases[J]. Chinese Heart Journal, 2021, 33(2): 199-204. DOI: 10.12125/j.chj.202009015

    ADAM17与心血管疾病的相关性研究进展

    Research advance in correlation between a disintegrin and metalloproteinase 17 (ADAM17) and cardiovascular diseases

    • 摘要: ADAM17又称TNF-α转化酶(TNF-α converting enzyme,TACE)是一种去整合素-金属蛋白酶(a disintegrin and metalloproteases,ADAMs),通过对膜蛋白进行切割、使胞外片段从细胞膜表面脱落而调控细胞对外界刺激反应,也被称为细胞中的“分子剪刀”。ADAM17介导膜蛋白表皮生长因子受体(epidermal growth factor receptor,EGFR)配体、TNF-α、ICAM-1、VCAM-1、ACE2、VEGFR2等切割脱落,激活或阻断相关细胞信号通路,参与冠心病、动脉瘤、心力衰竭、高血压等心血管疾病过程,未来可能成为心血管疾病的防治靶点。

       

      Abstract: ADAM17, also known as TNF-α converting enzyme (TACE), is a member of a disintegrin and metalloproteases (ADAMs) family, which cuts off the ectodomain of membrane proteins and then regulates the cell’s responsiveness to external stimuli. It is called "molecular scissors" based on its important roles in multiple cell processes. ADAM17 mediates the cleavage of EGFR ligands, TNF-α, ICAM-1, VCAM-1, ACE2 and VEGFR2, thus participating in the pathological process of many cardiovascular diseases and adverse events such as coronary heart disease, aneurysm, heart failure and hypertension. ADAM17 may be a promising target for the prevention and treatment of cardiovascular diseases in the future.

       

    /

    返回文章
    返回